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Abstract. The electroencephalographic (EEG) sleep of 20 anorexic patients, 10 
bulimic patients, and 10 age-matched healthy controls was studied. In addition, six 
anorexic patients and six bulimic patients had a cholinergic rapid eye movement 
(REM) sleep induction test (RIT) performed with the cholinergic agent RS 86. The 
three samples showed no major differences in sleep patterns. The same held true 
when attention was focused on patients who additionally met D&U-Illcriteria for 
major depression. The RIT results were similar in the patients with eating disorders 
and in controls, but differed from those reported in depressives. Therefore, the 
present study found no hints of depression-like sleep patterns in patients with 
eating disorders. 
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The last decade has witnessed increased research interest in eating disorders such as 
anorexia nervosa and bulimia. The most prominent lines of inquiry were clinical 
reports, family history, treatment studies, and followup investigations. Some of this 
research indicated that eating disorders and affective disorders may be related psychi- 
atric disturbances (for overview of literature, see Halmi, 1985; Levy and Dixon, 1985; 
Swift et al., 1986). Such a relationship would have important theoretical and clinical 
implications. To date, however, there is still an ongoing discussion as to whether the 
mood disturbance is secondary to the eating disorder (e.g., Bruch, 1973; Fairburn, 
1983) or whether anorexia nervosa and bulimia both are variants of an affective 
disorder (e.g., Cantwell et al., 1977; Hudson et al., 1983). 
In sleep research, relatively little attention has been paid to the question of similari- 
ties between the sleep patterns of patients with eating disorders and those with 
affective disorders. This is surprising because abnormalities of rapid eye movement 
(REM) sleep (i.e., shortened REM latency and increased REM density) are generally 
accepted as characteristic biological abnormalities of primary depression (e.g., Gillin 
et al., 1984; Kupfer, 1986). 
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The first polysomnographic study in anorexic patients was carried out by Crisp et 
al. (1970), who reported poor sleep quality (frequent awakenings during the night, 
early morning awakening) as well as a decreased amount of slow wave sleep. These 
observations were replicated by subsequent studies (Lacey et al., 1975; Neil et al., 1980; 
Levy et al., 1987). Regarding REM sleep, three groups (Neil et al., 1980; Katz et al., 
1975; Walsh et al., 1985) reported shortened REM latencies in subgroups of anorexic 
patients. Most of these patients appeared to suffer from a concomitant affective 
disorder. 
The sleep in bulimic patients was found to be largely indistinguishable from that of 
normal controls (Walsh et al., 1985; Hudson et al., 1987; Levy et al., 1987). However, 
Walsh et al. (1985) reported a tendency toward shortened REM latencies in their 
depressed bulimic patients. Weilburg et al. (1985) observed a “REM-like” latency 
(these REM periods were rather short and flat in the electro-oculogram) of about 53 
min in two nondepressed bulimic patients. The only study comparing the sleep of 
bulimic patients with that of patients suffering from a primary affective disorder 
(Hudson et al., 1987) yielded a higher sleep continuity and a lower REM density in the 
bulimic patients. 
In particular, the observed REM sleep alterations in patients with eating disorder, 
mainly in those manifesting a concomitant affective disorder, seem to be comparable 
to those well known in depression and therefore support the assumed biological 
association between a subgroup of eating disorders and depression. 
Another possibility to test the assumption of a biological link between eating 
disorders and depression is provided by the cholinergic REM induction test (RIT). 
This test is based on the cholinergic-noradrenergic mbalance theory of depression 
(Janowsky et al., 1972) and the reciprocal interaction model of sleep regulation 
(Hobson et al., 1975; McCarleyand Hobson, 1975). In short, the i.v. administration of 
cholinergic agents like physostigmine or arecoline during sleep leads to a hastened 
onset of the subsequent REM period in healthy subjects. In depressives, this effect is 
significantly more pronounced (for overview, see Sitaram et al., 1984). The only study 
in which the RIT was carried out in patients with anorexia nervosa was performed by 
Sitaram et al. (1984). They reported 66% of the anorexics with a coexisting affective 
disorder to be arecoline responders. In patients with a primary depression, an areco- 
line response was observed in 71%. In contrast, in nondepressed anorexics and in 
healthy controls, the distributions of arecoline responders were low (12% and 25%, 
respectively). These observations, too, support a biological link between eating dis- 
orders and affective illness. 
Recently, an alternative cholinergic agent, RS 86, was studied by Spiegel (1984). As 
compared to physostigmine and arecoline, this drug has some important advantages. 
It is an orally acting central muscarinic agonist with minor peripheral side effects and 
has a long half-life of about 8 hours. Spiegel (1984) demonstrated that 1.5 mg RS 86 
hastened the onset of the first REM period in healthy volunteers. These results were 
replicated by our group (Riemann et al., 1988) and were extended to depressed 
patients (Berger et al., 1985, in press), who showed a significantly more pronounced 
shortening of REM latency when compared to age-matched healthy controls. 
The aims of the present study were twofold: (1) To elucidate further the sleep 
patterns of patients with eating disorders and (2) to test the assumption of an 
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association between eating disorders and affective disorders by conducting the choli- 
nergic RIT. 
Methods 
Subjects. Twenty patients (19 females, 1 male) with a diagnosis of anorexia nervosa (Feighner 
et al., 1972) were investigated. Mean age was 21.0 years and, on average, percentage of ideal 
body weight (IBW) was 70.3% (Metropolitan Life Insurance Company, 1959). In addition, we 
examined 10 normal-weight bulimic women who met DSM-HIcriteria (American Psychiatric 
Association, 1980) for this syndrome. Mean age was 23.2 years and mean body weight was 
98.0% of IBW. All subjects were inpatients on an open psychiatric ward and had received no 
psychotropic medication during the last 3 months before the study. 
All subjects were given the Composite International Diagnostic Interview (CIDI) (Semler et 
al., 1987) to assess the current and past diagnosis of major depression according to DSM-III 
criteria. Nine anorexic and five bulimic patients qualified for a current and/or a lifetime 
diagnosis of major depression. In addition, the severity of depressive symptomatology was rated 
by the depression-relevant items of the Inpatient Multidimensional Psychiatric Scale (IMPS-D: 
subscales INP, RTD, IMF) (Lorr et al., 1962); a cutoff value of 15% of the theoretically possible 
maximum distinguishes well between depressed and nondepressed psychiatric patients (Berger 
et al., 1982). 
The 10 healthy controls were carefully selected to match the age and gender distribution of the 
eating disorder samples. They were thoroughly screened for physical and psychiatric disorders 
and underwent an extensive semistructured psychiatric interview to ensure that they were free of 
a personal or family history of psychiatric disorders. In addition, their eating habits had to be 
undisturbed, and body weight had to be within the normal range (f 10% IBW). 
Sleep. On average, 11 days after hospital admission, all patients slept for 3 consecutive nights in 
the laboratory. The same was true for the control subjects. Sleep was recorded between lights 
out (2315h) and lights on (0630h) using standard procedures (electroencephalogram, electro- 
oculogram, and electromyogram). Records of night 3 were scored by two experienced raters 
according to standardized criteria (Rechtschaffen and Kales, 1968). REM latency was defined 
as the time interval from sleep onset (first occurrence of a sleep spindle/k complex) until the first 
epoch of REM sleep; REM density was defined as the ratio of 3-set mini-epochs per REM 
period including REMs to the total amount of all 3-set mini-epochs per REM period x 100%. 
Cholinergic REM Induction Test (RIT). In addition to baseline electroencephalographic 
(EEG) sleep recordings, six anorexic (5 female, 1 male; mean age: 22.5 f SD 3.1 years; mean body 
weight: 85.5 f SD 5.1% IBW; two of them displayed a current major depression) and six bulimic 
females (mean age: 21.5 f SD 2.7 years; mean body weight: 91.5 f SD 7.7% IBW; three with a 
current and one also with a lifetime diagnosis of major depression) participated in the RIT. On 
average, the severity of depressive symptomatology in these 12 patients was moderate (IMPS- 
D: 23.9 f SD 8.8% maximum value). In bulimic patients, the RIT was performed immediately 
after the baseline period. For safety reasons, the RIT was performed in anorexic patients when 
they had reached a body weight of at least 80% IBW. Thirteen young healthy subjects (8 females, 
5 males; mean age: 23.3 f SD 2.7 years) who were free of medical and psychiatric disorders and 
who had no history of affective disturbances erved as a control group. For the purpose of the 
RIT, 1.5 mg RS 86 and placebo were given at 2200h in a random order. Sleep was recorded as 
mentioned above. The subjects, who were informed in detail about the possible side effects of 
the drug and consented to participate, were blind to the placebo-drug regime. 
Statistics. Descriptive statistics include presentation of mean and standard deviations (SD). 
The Kruskal-Wallis H test was conducted to test group effects. Group comparisons were 
computed either by the Mann-Whitney U test (independent samples) or the Wilcoxon test 
(dependent samples). The level of significance was set at 5% (two-tailed). 
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Results 
The clinical characteristics of the subjects are presented in Table 1. Age and sex 
distributions were similar in all three groups. The percentage of IBW was significantly 
lower in the anorexic patients as compared to the bulimic patients and the control 
subjects @ < 0.001). In both anorexic and bulimic patients, body weight did not 
change between hospital admission and time of study (means: 0.2 and 0.0 %IBW, 
respectively). The bulimic patients were more depressed than the anorexic patients @ 
< O.OOl), and their illness lasted for a longer time (p < 0.01). The distribution of 
patients with a concomitant major depression was similar in both samples. 
Table 1. Clinical characteristics 
Anorexia 
nervosa Bulimia Controls 
(n = 20) (n = 10) (n = 10) 
Sex (F/M) 19/l 1 o/o 9/l 
Age 21.0 + 3.1 23.2 k 3.1 23.1 + 3.1 
(20.0) (23.0, (23.0) 
Duration of illness 39.0 k 33.4 77.4 + 25.7 - 
(months) (30.0) (81.0) 
% Ideal body weight 70.3 f 6.3 98.0 +_ 15.5 96.0 f 5.9 
(71.5) (92.5) 195.01 
Restricters/ 11 (55%) 0 
History of anorexia 6 (60%) 0 
Major depression 9 (45%) 5 (50%) 0 
Severity of depression 19.5 z!z 8.4 29.7 k 8.0 - 
(IMPS-D; % max. value) (19.7) (30.5) 
Nom. F = female. M = male. IMPS-D = Inpatient Multidimensional Psychiatric Scale, depression-relevant 
subscales. Max = maximum. Major depression diagnosed according to DSM-III. Means, SDS, and medians iin 
parentheses) are presented. 
The results for the sleep parameters tudied are presented in Table 2. Sleep conti- 
nuity did not differ among the three samples, except for a significantly lower sleep 
efficiency in the bulimic patients as compared to the controls (p < 0.05) indicated by 
increased intermittent wakefulness in the bulimic patients 0, < 0.05). The sleep 
architecture of all three groups appeared quite similar. Likewise, REM sleep 
measures-in particular, REM latency-did not differ among the groups. 
Spearman rank correlations were computed to investigate associations among 
clinical characteristics and sleep measures. The strongest links were observed in the 
bulimic patients: age showed a significant negative correlation with REM latency (I = 
-0.65, p < 0.05) and percentage of slow wave sleep (SWS) (r = -0.87, p < 0.01). 
Furthermore, age showed a significant positive correlation with early morning awak- 
ening (EMA) (r = 0.67, p < 0.05). In anorexic patients, all age-related coefficients were 
nonsignificant. The same was observed in the controls, except for a strong positive 
correlation between age and intermittent ime awake (F= 0.83,~ < 0.01). Percentage of 
IBW, duration of illness, and severity of depression (IMPS-D) were not correlated 
with any sleep measures, including those of REM sleep. 
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Table 2. Sleep variables in anorexia, bulimia, and controls 
Anorexia Bulimia Controls 
(n = 20) (n = 10) (n = 10) 
Sleep period time (min) 
Total sleep time (min) 
Sleep efficiency (%) 
Sleep onset latency (min) 
intermittent awake (min) 
Early morning awake (min) 
Stage 2 (% SPT) 
SWS (% SPT) 
REM (% SPT) 
REM latency (min) 
REMP 1 duration (min) 
REMP 1 density (%) 
Mean REM density (%) 
408.8 * 27.5 
392.5 + 37.5 
90.2 + 6.8 
14.9 I!z 13.0 
15.9? 18.4 
10.8 2 16.8 
50.1 t 9.3 
20.2 ? 10.1 
19.2 f 6.5 
69.4 + 26.1 
14.7 ? 14.9 
19.7 + 7.4 
25.8 f 8.5 
408.3 4 32.7 
386.6 2 33.8 
87.9 + 6.7 
22.1 + 17.6 
21.1 2 23.7 
9.6 + 19.1 
46.2 i- 12.9 
18.5 t 9.1 
20.4 + 6.1 
94.0 + 79.1 
19.3 + 17.1 
20.3 + 12.0 
28.0 4 9.8 
413.7 f 17.0 
405.4 + 19.1 
93.3 f 4.3 
19.0 + 10.6 
7.8 f 11 .O 
2.4 + 4.8 
52.1 f 5.7 
19.6 2 7.6 
19.4 + 3.7 
72.0 f 31.5 
14.6 ? 8.6 
22.4 ? 8.5 
32.2 f 10.5 
Note. SPT = sleep period time. SWS = slow wave sleep. REM = rapid eye movement. REMP = REM period. Values 
are mean k SD. 
The clustering of the nine anorexic and five bulimic patients with a concomitant 
diagnosis of a major depression and those without resulted in a similar distribution of 
age, gender, and body weight of these two groups. The severity of depressive sympto- 
matology tended to be increased in the depressed sample (IMPS-D: mean f SD = 25.8 
f 9.7%) as compared to the nondepressed patients (20.3 + 8.8%,p<O.O8). With regard 
to sleep measures, the depressed eating disorder patients exhibited a significantly later 
final awakening than their nondepressed counterparts (3.4 + 8.3 min and 16.6 = 20.7 
min, respectively; p < 0.05), and their relative amount of SWS was increased (23.0 f 
10.1% and 16.7 * 8.470, respectively; p < 0.05). Again, REM sleep variables did not 
differ among the groups. Fig. 1 shows that in all samples the distribution of REM 
latency was nearly identical. The only two subjects exhibiting a REM latency <45 min 
were a restricting anorexic and a bulimic patient without an anorexic history, both 
nondepressed. 
Sleep was similar in both depressed and nondepressed anorexic patients. As com- 
pared to their nondepressed counterparts, the depressed bulimic patients had signifi- 
cantly less EMA (means: 0.2 ? 0.3 vs. 19.0 f 24.4 min;p< 0.05). No further differences 
were observed. 
REM Induction Test (RIT). The RIT was performed in 12 patients with an eating 
disorder (6 anorexics and 6 bulimics) and in 13 healthy controls. The age distribution 
was similar in the patient sample and in the controls (21.9 It 2.8 years and 23.3 * 2.7 
years, respectively). 
The placebo sleep measures were similar in both groups, except that a significantly 
shorter sleep period time was observed in the patients with eating disorders @ < 0.05). 
After the administration of 1.5 mg RS 86, REM latency was significantly shortened in 
both the patients suffering from eating disorders and the healthy controls (Table 3). 
On average, the degree of shortening was nonsignificantly more pronounced in the 
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Table 3. Sleep patterns in eating disorders (n = 12) and healthy controls 
(n = 13) during placebo and RS 88 nights 
Eating disorders Controls 
Placebo RS86 p< Placebo RS88 p-= 
Sleep period 383.3+49.31 398.2k23.6 419.3k17.6 412.8?19.2 
Sleep efficiency (%) 67.5+10.9 87.3k11.3 94.1+ 3.9 92.4+ 3.1 0.05 
Intermittent awake 10.7+17.7 21.2k26.5 9.7f 9.4 13.0t10.1 
Sleep onset latency 14.9k12.4 18.9+11.0 14.0flO.O 17.0+ 7.4 
SWS % SPT 22.72 8.2 10.91 9.8 0.01 20.02 7.5 14.4f 7.4 0.01 
REM % SPT 20.32 4.2 22.02 5.2 18.35 2.8 21.04 3.6 0.05 
REM latency 75.2222.2 53.3k22.5 0.01 71.0227.2 61.3k30.7 0.05 
REMP 1 duration 14.3? 8.2 19.9+13.8 11.5* 9.4 17.6212.2 
REMP 1 density (%) 21.74 7.1 26.4k12.0 26.OY2.8 27.2212.0 
Mean REM density (O/O) 28.9? 4.2 29.0?10.2 34.3k11.8 33.72 9.7 
Note. SWS = slow wave sleep. SPT = sleep period time. REM = rapid eye movement. REMP = REM period. Values 
are mean ? SD; units are min unless otherwise specified. The p values were obtained using the Wilcoxon test, 
1. p c 0.05. comparison to healthy controls-placebo, U test. 
patients with an eating disorder (mean: 21.9 f 15.7 min) than in the controls (mean: 9.8 
* 35.4 min;p < 0.30). In the controls, the lower mean shortening of REM latency can 
be mainly attributed to the fact that after the application of RS 86 one subject 
probably skipped the first REM period and therefore exhibited a lengthening of REM 
latency of 93 min (Fig. 2). Furthermore, REM latencies of the depressed (n = 6) and the 
nondepressed (n = 6) patients with eating disorders were similar during the placebo 
night (means: 69.6 f 7.4 vs. 81.0 f 30.6; p <0.65) as well as during the drug night 
(means: 50.2 f 6.8 vs. 56.3 f 32.3; p < 0.75). During the drug night, the only patient 
showing a REM latency < 25 min was a nondepressed bulimic. 
Regarding sleep architecture, in both the patients suffering from eating disorders 
and in healthy subjects, the percentages of SWS were significantly decreased during 
the drug nights. In addition, percentage of REM sleep was significantly increased in 
the controls (Table 3). In both samples, phasic REM sleep events were unaffected by 
RS 86. 
Discussion 
We found no major differences among the all-night sleep EEGs in anorexic and 
bulimic patients, and age- and gender-matched healthy controls. These results support 
recent findings of Walsh et al. (1985) Levy et al. (1987), and Hudson et al. (1987), who 
reported sleep patterns in their normal-weight bulimic patients which were similar to 
those in healthy controls and anorexic patients. The observed similarity of sleep in 
anorexic patients and healthy controls, however, seems to contradict some earlier 
reports in which the most robust findings were a disturbance of sleep continuity 
measures (Crisp et al., 1970; Lacey et al., 1975; Foster et al., 1976; Walsh et al., 1985) 
and a reduction of SWS or REM sleep(Crisp et al., 1970; Foster et al., 1976; Neilet al., 
1980; Levy et al., 1987). Furthermore, REM latency was shortened in the overall 
sample of anorexic patients (Katz et al., 1984) or in certain subgroups (Neil et al., 1980; 
Fig. 1. Distribution of REM latency 
in anorexic, bulimic, and healthy 
subjects 
Fig. 2. Distribution of REM latency 
during the RIT in patients with 
eating disorders and healthy 
subjects 
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Walsh et al., 1985). Some methodological differences between these studies and the 
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present one may serve to explain discrepancies in results. Crisp et al. (1970) and Lacey 
et al. (1975) focused on sleep changes during weight restoration and reported the sleep 
to be disturbed at admission. These studies did not include healthy controls. On the 
other hand, Foster et al. (1976) did not observe a marked disturbance in sleep 
continuity at the time of admission but after a refeeding period in their anorexic 
patients as compared to controls. The possible influence of weight gain on sleep seems 
very unlikely in the present study, as there was no weight change in either the anorexic 
or the bulimic patients between hospital admission and the time of study. Walsh et al. 
(1985) reported sleep data for night 1 and for night 2 during which the subjects slept 
with an i.v. catheter. Both conditions are known to induce arousals in the sleep of 
healthy subjects (Coble et al., 1974; Browman and Cartwright, 1980; Adam, 1982; 
Jarrett et al., 1984). To minimize the possible contamination of the sleep data by 
adaptation effects, we analyzed the polysomnograms of only night 3. The inconsis- 
tently reported reduction of SWS may be due to different characteristics of the 
samples investigated. Levy et al. (1987) reported a low amount of SWS, especially in 
the dietary restricting anorexic patients. Another possible influence on sleep architec- 
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ture may be that of varying compositions of nourishment. Phillips et al. (1975) 
demonstrated in healthy subjects that diets containing different proportions of basic 
constituents (e.g., carbohydrate and fat) affected the amount of SWS or REM sleep to 
a different degree. 
A further important factor influencing sleep is an affective illness. REM sleep 
abnormalities are a common feature in patients suffering from a primary depressive 
disorder (e.g., Gillin et al., 1984). Therefore, the observation of shortened REM 
latencies in patients with eating disorders, especially in depressed subsamples, is cited 
as a hint for the assumed biological link between eating and affective disorders (Neil et 
al., 1980; Katz et al., 1984; Walsh et al., 1985). However, Katz et al. (1984) and Walsh 
et al. (1985) diagnosed their patients according to DSM-III criteria which do not 
exclude patients with a primary depression as is the case with the Feighner criteria. 
Neil et al. (1980) used the Feighner criteria but also included patients with secondary 
anorexia in which primary depression can be present. Therefore, it cannot be ruled out 
that in these studies the observed shortened REM latencies might be due to patients 
suffering from a primary depression. In the present study, we investigated the sleep 
characteristics of patients with eating disorders (according to Feighner criteria in 
anorexic patients) who additionally fulfilled DSM-III criteria for major depression. 
The obtained observations were not in line with the assumption of “depression-like” 
sleep abnormalities in depressed anorexic and depressed bulimic patients, thus sup- 
porting the similar findings of Levy et al. (1987) and Hudson et al. (1987). In 
particular, this applies to REM sleep measures such as REM latency and both the 
duration and density of REM period 1. The only two patients exhibiting a REM 
latency < 45 min were both nondepressed. Furthermore, the severity of depression 
was not correlated with any sleep measures, and in particular was not correlated with 
REM sleep measures. However, it should be mentioned that age was negatively 
associated with REM latency in bulimic patients. This link is reported to be typical in 
depression and does not characterize healthy subjects (Ulrich et al., 1980; Gillin et al., 
1981; Kupfer et al., 1982; Lahmeyer et al., 1983). 
Moreover, the results of the cholinergic RIT do not support the assumed biological 
link between eating and affective disorders. Indeed, after administration of the choli- 
nomimetic agent RS 86 in the patients with eating disorders, a hastened onset of REM 
period 1 and a reduction of SWS was observed, thus seeming to mimic depression-like 
sleep patterns. However, these effects of RS 86 on sleep did not differ between 
depressed and nondepressed patients with eating disorders and were quite similar to 
those observed in young healthy subjects. Recently, Berger et al. (1985, in press) 
demonstrated that the effect of 1.5 mg RS 86 on REM latency in depressed patients 
was significantly more pronounced (means: 58.1 min vs. 15.1 min) than in age- 
matched healthy subjects (74.1 min vs 50.0 min). On the placebo night, a REM latency 
< 45 min was found in only 25% of the depressives, whereas on the drug night 88% of 
the patients had a REM latency < 25 min. These data support the assumption of a 
disturbance of the REM sleep regulating system during depression. If this does not 
become manifest during baseline sleep, as is true in young depressives (Taub et al., 
1978; Hawkins et al., 1985; Cashman et al., 1986; Goetz et al., 1987; Hudson et al., 
1987; Lauer et al., 1987) then it can be demasked by a cholinergic agent. In the present 
sample of patients with eating disorders, only one bulimic patient without a concomit- 
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ant diagnosis of a major depression had a REM latency < 25 min during the drug 
night. This observation is not in accord with the results reported by Sitaram et al. 
(1984), who found that 66% of anorexic patients with a coexisting affective disorder 
were arecoline responders (reduction of the second REM latency > 19 min) as 
compared to only 12% of the nondepressed anorexic patients. However, there are 
some differences in methodology and patient sample between the study of Sitaram et 
al. and our own study. They infused 0.5 mg arecoline 25 min after the end of REM 
period 1, and their depressed anorexics also had a personal and/ or family history of 
affective illness. In the present study, only one depressed bulimic patient had a 
personal history of an affective disorder. However, her REM latencies were well 
within the range of the total sample. Furthermore, the significance of an affective trait 
for the response to the RIT is put into question by the results reported by Berger et al. 
(in press), who observed no differential effects of RS 86 on sleep in entirely remitted 
depressives and healthy controls., In both samples, this effect was significantly minor 
as compared to patients suffering from a current episode of primary depression. The 
fact that we performed the RIT in the anorexic patients when they had reached a 
minimum of at least 80% of IBW does not seem to have been a significant factor since 
Sitaram et al. (1984) demonstrated that low- and normal-weight anorexic patients did 
not differ in response to the RIT. 
In conclusion, all-night sleep EEGs in anorexic and bulimic patients were largely 
indistinguishable from those in age-matched healthy controls. In addition, no 
depression-like sleep patterns were observed in the eating disorders, particularly in 
those suffering from a concomitant major depression. The results from the cholinergic 
RIT furthermore do not support the assumption of a biological link between eating 
disorder and depression. 
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